The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2023

Filed:

Jul. 09, 2021
Applicant:

Shihezi University, Shihezi, CN;

Inventors:

Chuangfu Chen, Shihezi, CN;

Peng Wu, Shihezi, CN;

Chencheng Xiao, Shihezi, CN;

Chengyao Li, Shihezi, CN;

Yong Wang, Shihezi, CN;

Zhen Wang, Shihezi, CN;

Assignee:

Shihezi University, Shihezi, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C07K 16/10 (2013.01); G01N 33/56983 (2013.01); C07K 2317/569 (2013.01); C07K 2317/76 (2013.01); G01N 2333/165 (2013.01);
Abstract

A nanobody and its application based on SARS-CoV-2 S protein are provided, and the present disclosure relates to biomedical technology. The present disclosure chooses the Spike S1+S2 ECD of SARS-CoV-2 as a target, and screens the nanobody against of SARS-CoV-2 by using a nanobody library. After an ELISA test, the Spike S1+S2 ECD target of SARS-CoV-2 can be specifically identified while a SPIKE RBD target is identified, and a binding signal is relatively strong. The corresponding nanobody sequence is constructed into a prokaryotic expression vector for expression and purification to express the target nanobody successfully. After the purification, the purity is greater than 90%. The ELISA test of VHH nanobody showed that the purified nanobody has higher affinity to the two targets.


Find Patent Forward Citations

Loading…